Get my own profile
Public access
View all39 articles
6 articles
available
not available
Based on funding mandates
Co-authors
Torleif HärdProfessor of Structural Molecular Biology, SLU, UppsalaVerified email at slu.se
Daniel Martinez MolinaCSO at Pelago Bioscience, SwedenVerified email at pelagobio.com
Par NordlundKarolinska InstitutetVerified email at ki.se
Rozbeh JafariKarolinska InstitutetVerified email at ki.se
Brinton Seashore-LudlowKarolinska InstitutetVerified email at ki.se
Mats LarhedProfessor in Medicinal Chemistry, Uppsala UniversityVerified email at ilk.uu.se
Thomas HelledayKarolinska InstitutetVerified email at ki.se
Karin EngenResearcher at Uppsala UniversityVerified email at ilk.uu.se
Per ArturssonUppsala universityVerified email at farmaci.uu.se
Martin ScobieKarolinska InstitutetVerified email at scilifelab.se
Martin HaraldssonKarolinska InstitutetVerified email at ki.se
John LadburySchool of Molecular and Cellular Biology, University of LeedsVerified email at leeds.ac.uk
Ann-Sofie JemthKarolinska InstituteVerified email at scilifelab.se
André MateusAssistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)Verified email at umu.se
Jonas SävmarkerScientific Director, Orexo ABVerified email at orgfarm.uu.se
Kristmundur SigmundssonPrincipal Scientist, Duke-NUS Med. School, SGVerified email at duke-nus.edu.sg
Stefan KnappUniversity of FrankfurtVerified email at pharmchem.uni-frankfurt.de
Evert HomanKarolinska InstitutetVerified email at ki.se
Pål StenmarkStockholm UniversityVerified email at dbb.su.se
Carmen Medina LlanosUppsala UniversityVerified email at uu.se
Follow![Thomas Lundbäck](https://usercontent.cljtscd.com/citations?view_op=view_photo&user=mMlYx30AAAAJ&citpid=4)
Thomas Lundbäck
Senior Director - Assays, Profiling and Cell Sciences, Discovery Sciences, R&D, AstraZeneca
Verified email at astrazeneca.com - Homepage